Does Adding Avastin to Tarceva Help EGFR Positive Lung Cancer Patients?

Update: 2014-06-12

Description

Drs. Nasser Hanna, Melissa Johnson and Jack West discuss results of a phase 2 trial presented at ASCO 2014 that studied if adding Avastin (bevicizumab) to Tarceva helped EGFR positive lung cancer patients increase progression-free survival. June 2014.

Comments

In Channel

Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy?

2014-07-3104:36

Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation?

2014-07-2705:28

Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?

2014-07-2202:27

Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment?

2014-07-1707:28

Zykadia for ALK Positive Lung Cancer: New Drug, New Hope

2014-07-1307:22

What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer

2014-07-0803:52

MET-Amplified Lung Cancer: A New Target for XALKORI?

2014-07-0307:18

CO1686 - 3rd Generation Drug for Acquired Resistance in EGFR Lung Cancer

2014-06-2904:10

FGFR and Its Role in Treating Squamous Cell Lung Cancer

2014-06-2502:21

AZD9291 for Acquired Resistance in EGFR Positive Lung Cancer

2014-06-2411:36

What Are Heat Shock Protein (HSP) 90 Inhibitors and How May They Help Fight Lung Cancer?

2014-06-2302:17

The Promise of Immunotherapy in Lung Cancer

2014-06-1801:21

Does Gilotrif Help EGFR Positive Lung Cancer Patients?

2014-06-1808:16